What is palliative surgery for liver cancer?

Sep 22, 2025 Source: Cainiu Health
Dr. Gao Jun
Introduction
In general, palliative surgery for liver cancer is a surgical approach aimed at patients with unresectable tumors, focusing on symptom relief, improvement of quality of life, and prolongation of survival. It does not aim for complete tumor removal, but rather addresses urgent or life-impacting problems caused by the tumor. Palliative surgery serves as an important treatment option for patients with advanced liver cancer or those who are medically unfit for curative surgery.

Generally, palliative surgery for liver cancer is a surgical approach aimed at patients with unresectable tumors, focusing on symptom relief, improved quality of life, and prolonged survival. It does not aim for complete tumor removal, but rather targets urgent or life-impacting complications caused by the tumor. Detailed analysis is as follows:

Palliative liver cancer surgery is primarily indicated in two scenarios. First, when the tumor has extensively invaded the liver—such as multifocal lesions, invasion of major blood vessels, or distant metastases—making curative resection impossible. Second, when the patient's overall health is poor, such as those with severe cirrhosis or compromised cardiopulmonary function, who cannot tolerate radical surgery. Surgical procedures are symptom-oriented and commonly include local tumor ablation techniques like radiofrequency or microwave ablation to destroy part of the tumor tissue, hepatic arterial chemoembolization, biliary stent placement, and variceal band ligation for esophageal and gastric varices.

The key value of these procedures lies in palliative symptom reduction rather than tumor cure. They can effectively alleviate symptoms such as pain, jaundice, and bleeding, help patients maintain basic daily functioning, and create favorable conditions for subsequent treatments such as targeted therapy or immunotherapy.

Therefore, palliative surgery for liver cancer is an important treatment option for patients with advanced disease or those unfit for curative surgery. Although it cannot eradicate the tumor, it significantly improves quality of life and buys time for comprehensive treatment strategies. Its implementation should be evaluated by a multidisciplinary team based on the individual patient’s clinical condition.

Related Articles

View All